(Valerian) for Improving Sleep in Patients With Cancer Receiving Adjuvant Therapy

Completed · Phase 3 · Has a placebo group

Conditions studied: Fatigue, Sleep Disorders, Unspecified Adult Solid Tumor, Protocol Specific

In brief

RATIONALE: The herb Valeriana officinalis (valerian) may promote sleep. It is not yet known whether valerian is effective in improving sleep in patients who are receiving adjuvant therapy for cancer. PURPOSE: This randomized phase III trial is studying how well valerian improves the quality of sleep in patients who are receiving adjuvant therapy (radiation therapy, chemotherapy, or hormone therapy) for cancer.

Key facts

Study ID
NCT00075842
Run by
Alliance for Clinical Trials in Oncology
People needed
227
Starts
2003-08-01
Expected to finish
2010-01-01
Last updated by the study team
2016-12-06

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.